Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Earlier Pradaxa Settlements Do Not Stop Filing Of New Pradaxa Lawsuits

March 23, 2017 By Law Offices of Thomas J. Lamb, P.A.

As can be seen from the following set of drug safety alerts, Pradaxa has caused significant concern among doctors and patients since soon after it first became available for use in the US. In early December 2011 the FDA announced it would evaluate reports of bleeding in patients taking Pradaxa that have been submitted to the agency’s Adverse … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding events, bleeding risk, drug injury, drug side effects, Gastrointestinal (GI) Bleeds, Pradaxa, Uncontrollable Bleeding Events

Eliquis MDL For Federal Lawsuits; In California, JCCP Petition Pending

February 14, 2017 By Law Offices of Thomas J. Lamb, P.A.

In the federal court system, there are now more than 50 Eliquis lawsuits filed, and more of these drug injury and death cases are expected. Given this situation, in early February 2017 the United States Judicial Panel on Multidistrict Litigation (JPML) established this consolidation of all federal court Eliquis cases, IN RE: ELIQUIS (APIXABAN) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury lawsuits, Eliquis, Uncontrollable Bleeding Events

Defendants BMS And Pfizer Ask For Eliquis Federal Court Consolidation

November 11, 2016 By Law Offices of Thomas J. Lamb, P.A.

On October 13, 2016 attorneys for Bristol-Myers Squibb Company and Pfizer Inc. filed with the United States Judicial Panel on Multidistrict Litigation (JPML) this court document, “BRISTOL-MYERS SQUIBB COMPANY AND PFIZER INC.’S MOTION FOR TRANSFER OF RELATED ELIQUIS (APIXABAN) PRODUCTS LIABILITY ACTIONS FOR COORDINATED PRETRIAL PROCEEDINGS PURSUANT … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding events, bleeding risk, Eliquis, Gastrointestinal (GI) Bleeds, Uncontrollable Bleeding Events

Is Eliquis A Safe Alternative To Warfarin For Patients On Dialysis?

November 3, 2016 By Law Offices of Thomas J. Lamb, P.A.

In this article published online by Pharmacy Times in August 2016, “Is Apixaban Safe and Effective for Patients on Hemodialysis?”, Brandon Dyson, PharmD, BCPS, who is a clinical pharmacist at an academic medical center, puts some scrutiny on Eliquis, an increasingly popular blood-thinner drug: [Eliquis (apixaban)] is the only [novel oral … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding events, bleeding risk, Eliquis, Gastrointestinal (GI) Bleeds, Uncontrollable Bleeding Events

No Clinical Trials Comparing The Safety Of Eliquis To Xarelto Done Yet

October 26, 2016 By Law Offices of Thomas J. Lamb, P.A.

In two medical study reports it seemed that Xarelto (rivaroxaban) was more likely to be involved in a serious bleeding event as an adverse reaction than was either Pradaxa (dabigatran) or Eliquis (apixaban). Earlier this month the medical journal Chest published this article, “Direct comparison of dabigatran, rivaroxaban, and apixaban for … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding risk, Eliquis, Hemorrhages, Prad, Savaysa, Uncontrollable Bleeding Events, Xarelto

Eliquis Lawsuits Being Filed Across The Country In Increasing Numbers

September 19, 2016 By Law Offices of Thomas J. Lamb, P.A.

It is important to know that as of September 2016 Eliquis does not currently have an FDA-approved antidote, or reversal agent, for a patient experiencing a trauma-induced bleeding event or needing emergency surgery. Eliquis (apixaban) was approved by the FDA in December 2012. These serious medical conditions have been associated with the use of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding risk, Eliquis, Gastrointestinal (GI) Bleeds, Hemorrhages, Strokes, Uncontrollable Bleeding Events

Antidote Drug For Xarelto / Savaysa / Eliquis Is Denied FDA Approval

August 24, 2016 By Law Offices of Thomas J. Lamb, P.A.

The following Factor Xa inhibitors, which serve as blood-thinner drugs, are being used by an increasing number of patients for stroke prevention and for treatment of deep vein thrombosis and pulmonary embolism: Eliquis (apixaban) from Pfizer/Bristol-Myers Squibb; Xarelto (rivaroxaban) from Bayer/Johnson & Johnson; and, Savaysa … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Eliquis, Savaysa, Uncontrollable Bleeding Events, Xarelto

New Studies Investigate Long-Term Anticoagulation Use & Bleeding Risk

August 1, 2016 By Law Offices of Thomas J. Lamb, P.A.

According to a Patient-Centered Outcomes Research Institute (PCORI) press release from earlier this month, the PCORI Board of Governors approved $6.5 million for research to compare the potential benefits and harms of popular anticoagulant drugs. The study will include the older anticoagulant, Coumadin (warfarin), as well as the newer "novel … [Read more...]

Filed Under: Unsafe Drugs Tagged With: anticoagulants, bleeding risk, drug injury, Eliquis, Pradaxa, Savaysa, Uncontrollable Bleeding Events, Xarelto

Doctors Are Concerned About Lack Of Savaysa Antidote To Stop Bleeding

July 7, 2016 By Law Offices of Thomas J. Lamb, P.A.

I think it is interesting how this recent Healio – HemOnc Today news reports, “Edoxaban safe, effective for extended prevention of recurrent VTE”, ends by focusing on the continuing lack of any FDA-approve antidote for Savaysa, as well as Eliquis and Xarelto. The growing availability of agents for the reversal of bleeding caused by direct oral … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Eliquis, Savaysa, Uncontrollable Bleeding Events, Xarelto

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.